Japan approves Pfizer COVID vaccine for children aged 5 to 11Japan’s health ministry has authorised the use of Pfizer and BioNTech COVID-19 vaccine in children aged between five Share XJapan approves Pfizer COVID vaccine for children aged 5 to 11https://pharmaphorum.com/news/japan-approves-pfizer-covid-vaccine-for-children-aged-5-to-11/
27 drugmakers to provide generic COVID drug to low-income countriesTwenty-seven drug makers have signed onto a deal to manufacture a generic version of molnupiravir, Merck’s oral antiviral Share X27 drugmakers to provide generic COVID drug to low-income countrieshttps://pharmaphorum.com/news/27-drugmakers-to-provide-generic-covid-drug-to-low-income-countries/
UK green lights Gilead Sciences, Galapagos ulcerative colitis drugThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Jyseleca (filgotinib) 200mg tablets to treat ulcerative Share XUK green lights Gilead Sciences, Galapagos ulcerative colitis drughttps://pharmaphorum.com/news/uk-green-lights-gilead-sciences-galapagos-ulcerative-colitis-drug/
Glenmark and Lotus partner on allergic rhinitis sprayThe mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma Share XGlenmark and Lotus partner on allergic rhinitis sprayhttps://pharmaphorum.com/news/glenmark-and-lotus-partner-on-allergic-rhinitis-spray/
Gilead takes legal action against counterfeit HIV drug networkUS pharma giant Gilead Sciences has accused a network of unauthorised suppliers and distributors of selling more than Share XGilead takes legal action against counterfeit HIV drug networkhttps://pharmaphorum.com/news/gilead-takes-legal-action-against-counterfeit-hiv-drug-network/
Endo, Florida reach $65M opioid settlementEndo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Share XEndo, Florida reach $65M opioid settlementhttps://pharmaphorum.com/news/endo-florida-reach-65m-opioid-settlement/
Sugemalimab plus chemo boosts lung cancer survival, trial revealsLung cancer drug sugemalimab has delivered positive results following a phase 3 trial. The GEMSTONE-302 study evaluated the Share XSugemalimab plus chemo boosts lung cancer survival, trial revealshttps://pharmaphorum.com/news/sugemalimab-plus-chemo-boosts-lung-cancer-survival-trial-reveals/
BioTuring enters collaboration to enable detailed single-cell RNA researchResearch into single-cell sequencing has been boosted with Single Cell Discoveries and BioTuring joining forces to refine the Share XBioTuring enters collaboration to enable detailed single-cell RNA researchhttps://pharmaphorum.com/news/bioturing-collaboration-detailed-single-cell-rna-research/
Billionaire-backed “rejuvenation” start-up Altos Labs launches operationsJust months after the venture was unveiled, controversial biotechnology company Altos Labs has officially launched with $3 billion Share XBillionaire-backed “rejuvenation” start-up Altos Labs launches operationshttps://pharmaphorum.com/news/billionaire-backed-rejuvenation-start-up-altos-labs-launches-operations/
